These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 35137936
1. Optimized method for normal range estimation of standardized uptake values (SUVmax, SUVmean) in liver SPECT/CT images with somatostatin analog [99mTc]-HYNIC-TOC (Tektrotyd). Piwowarska-Bilska H, Kurkowska S, Birkenfeld B. Nucl Med Rev Cent East Eur; 2022; 25(1):37-46. PubMed ID: 35137936 [Abstract] [Full Text] [Related]
2. Quantitative analysis of standardized uptake values (SUV) of metastatic bone lesions in scintigraphy with [99mTc]Tc-EDDA/HYNIC-Tyr3-octreotide in patients with neuroendocrine tumours. Malarz MM, Birkenfeld B, Piwowarska-Bilska H. Nucl Med Rev Cent East Eur; 2024; 27(0):31-35. PubMed ID: 39162352 [Abstract] [Full Text] [Related]
3. Characterisation of 99mTc EDDA/HYNIC-TOC (Tektrotyd) physiological and neuroendocrine tumour uptake using SPECT/CT standardised uptake values: initial experience. Reilly C, Gemmell AJ, McLaughlin IM, Fleming R, Reed N, McIntosh D, Nicol A. Nucl Med Commun; 2021 Aug 01; 42(8):935-939. PubMed ID: 33741866 [Abstract] [Full Text] [Related]
4. Influence of PET/CT 68Ga somatostatin receptor imaging on proceeding with patients, who were previously diagnosed with 99mTc-EDDA/HYNIC-TOC SPECT. Madrzak D, Mikołajczak R, Kamiński G. Nucl Med Rev Cent East Eur; 2016 Aug 01; 19(2):88-92. PubMed ID: 27479886 [Abstract] [Full Text] [Related]
6. 99mTc-HYNIC-TOC increased uptake can mimic malignancy in the pancreas uncinate process at somatostatin receptor SPECT/CT. Yamaga LY, Neto GC, da Cunha ML, Osawa A, Oliveira JC, Fonseca RQ, Nogueira SA, Wagner J, Funari MG. Radiol Med; 2016 Mar 01; 121(3):225-8. PubMed ID: 26558391 [Abstract] [Full Text] [Related]
8. Patient-specific radiation dosimetry of 99mTc-HYNIC-Tyr3-octreotide in neuroendocrine tumors. Grimes J, Celler A, Birkenfeld B, Shcherbinin S, Listewnik MH, Piwowarska-Bilska H, Mikolajczak R, Zorga P. J Nucl Med; 2011 Sep 01; 52(9):1474-81. PubMed ID: 21795364 [Abstract] [Full Text] [Related]
9. Comparative analysis of 99mTc-depreotide and 99mTc-EDDA/HYNIC-TOC thorax scintigrams acquired for the purpose of differential diagnosis of solitary pulmonary nodules. Płachcińska A, Mikołajczak R, Kozak J, Rzeszutek K, Kuśmierek J. Nucl Med Rev Cent East Eur; 2006 Sep 01; 9(1):24-9. PubMed ID: 16791800 [Abstract] [Full Text] [Related]
10. Clinical application of SPECT-CT with 99mTc-Tektrotyd in bronchial and thymic neuroendocrine tumors (NETs). Sergieva S, Robev B, Dimcheva M, Fakirova A, Hristoskova R. Nucl Med Rev Cent East Eur; 2016 Sep 01; 19(2):81-7. PubMed ID: 27479885 [Abstract] [Full Text] [Related]
11. Feasibility of a streamlined imaging protocol in technetium-99m-Tektrotyd somatostatin receptor SPECT/CT. Al-Chalabi H, Cook A, Ellis C, Patel CN, Scarsbrook AF. Clin Radiol; 2018 Jun 01; 73(6):527-534. PubMed ID: 29397911 [Abstract] [Full Text] [Related]
12. A retrospective study of SPECT/CT scans using SUV measurement of the normal pelvis with Tc-99m methylene diphosphonate. Wang R, Duan X, Shen C, Han D, Ma J, Wu H, Xu X, Qin T, Fan Q, Zhang Z, Shi W, Guo Y. J Xray Sci Technol; 2018 Jun 01; 26(6):895-908. PubMed ID: 30103368 [Abstract] [Full Text] [Related]
17. Limitations and pitfalls of 99mTc-EDDA/HYNIC-TOC (Tektrotyd) scintigraphy. Garai I, Barna S, Nagy G, Forgacs A. Nucl Med Rev Cent East Eur; 2016 Jun 01; 19(2):93-8. PubMed ID: 27479887 [Abstract] [Full Text] [Related]
18. [Value of 68Ga-DOTA-TATE Positron Emission Tomography/Computed Tomography in the Localization of Culprit Tumors Causing Osteomalacia with Negative 99mTc-HYNIC-TOC Single Photo Emission Computed Tomography]. Zhang S, Wang L, Wang T, Xing HQ, Huo L, Li F. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Dec 20; 40(6):757-764. PubMed ID: 30606385 [Abstract] [Full Text] [Related]